临床心身疾病杂志
臨床心身疾病雜誌
림상심신질병잡지
JOURNAL OF CLINICAL PSYCHOSOMATIC DISEASES
2014年
4期
14-15,18
,共3页
抑郁症%经络氧疗法%文拉法辛%联合治疗%汉密顿抑郁量表%抑郁自评量表
抑鬱癥%經絡氧療法%文拉法辛%聯閤治療%漢密頓抑鬱量錶%抑鬱自評量錶
억욱증%경락양요법%문랍법신%연합치료%한밀돈억욱량표%억욱자평량표
Depression%CAO%venlafaxine%therapeutic alliance%HAMD%SDS
目的:探讨文拉法辛联合经络氧疗法治疗抑郁症的临床疗效。方法将60例抑郁症患者随机分为两组,每组30例,两组均口服文拉法辛治疗,研究组联合经络氧疗法治疗,观察8周。采用汉密顿抑郁量表及抑郁自评量表评定临床疗效,副反应量表评定不良反应。结果治疗后两组汉密顿抑郁量表及抑郁自评量表评分均较治疗前显著下降(P<0.01),治疗各时段研究组各量表评分均显著低于对照组( P<0.01)。治疗8周末研究组显效率73.3%、有效率96.7%,对照组分别为56.7%、83.3%,两组比较差异均无显著性(χ2=1.83、2.96,P>0.05)。两组不良反应较轻微,发生率比较差异无显著性(P>0.05)。结论经络氧疗法对抑郁症的治疗有明显的增效作用;文拉法辛联合经络氧疗法治疗抑郁症起效快,疗效显著,安全性高,显著优于单用文拉法辛治疗。
目的:探討文拉法辛聯閤經絡氧療法治療抑鬱癥的臨床療效。方法將60例抑鬱癥患者隨機分為兩組,每組30例,兩組均口服文拉法辛治療,研究組聯閤經絡氧療法治療,觀察8週。採用漢密頓抑鬱量錶及抑鬱自評量錶評定臨床療效,副反應量錶評定不良反應。結果治療後兩組漢密頓抑鬱量錶及抑鬱自評量錶評分均較治療前顯著下降(P<0.01),治療各時段研究組各量錶評分均顯著低于對照組( P<0.01)。治療8週末研究組顯效率73.3%、有效率96.7%,對照組分彆為56.7%、83.3%,兩組比較差異均無顯著性(χ2=1.83、2.96,P>0.05)。兩組不良反應較輕微,髮生率比較差異無顯著性(P>0.05)。結論經絡氧療法對抑鬱癥的治療有明顯的增效作用;文拉法辛聯閤經絡氧療法治療抑鬱癥起效快,療效顯著,安全性高,顯著優于單用文拉法辛治療。
목적:탐토문랍법신연합경락양요법치료억욱증적림상료효。방법장60례억욱증환자수궤분위량조,매조30례,량조균구복문랍법신치료,연구조연합경락양요법치료,관찰8주。채용한밀돈억욱량표급억욱자평량표평정림상료효,부반응량표평정불량반응。결과치료후량조한밀돈억욱량표급억욱자평량표평분균교치료전현저하강(P<0.01),치료각시단연구조각량표평분균현저저우대조조( P<0.01)。치료8주말연구조현효솔73.3%、유효솔96.7%,대조조분별위56.7%、83.3%,량조비교차이균무현저성(χ2=1.83、2.96,P>0.05)。량조불량반응교경미,발생솔비교차이무현저성(P>0.05)。결론경락양요법대억욱증적치료유명현적증효작용;문랍법신연합경락양요법치료억욱증기효쾌,료효현저,안전성고,현저우우단용문랍법신치료。
Objective To explore the efficacy of venlafaxine combined with channel acupuncture plus oxy-gen (CAO) in depression and find out CAO synergism on depression .Methods Sixty depression patients were randomly divided into two groups of 30 ones each ,both groups took orally venlafaxine ,and research group was combined with CAO for 8 weeks .Efficacies were assessed with the Hamilton Depression Scale (HAMD) and Self-rating Depression Scale (SDS) and adverse reactions with the Treatment Emergent Symptom Scale (TESS) .Results The HAMD and SDS scores of both groups lowered more significantly after treatment compared with pretreatment (P<0 .01) ,those were significantly lower in research than control group at each time-point (P<0 .01) .At the end of the 8th week obvious effective and effective rate were respectively 73 .3% and 96 .7% in research and 56 .7% and 83 .3% in control group ,which showed no significant group differences (χ2 =1 .83、2 .96 ,P>0 .05) .Adverse reactions of both groups were mild and their incidences had no significant group differences (P>0 .05) .Conclusion CAO therapy has a signifi-cant synergism on depression treatment ;venlafaxine combined with CAO takes effect more rapidly and has an evident effect and higher safety compared with single venlafaxine in depression .